ciprofloxacin has been researched along with lactic acid in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (20.00) | 18.2507 |
2000's | 19 (38.00) | 29.6817 |
2010's | 20 (40.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brug, E; Meffert, R; Ritzerfeld, W; Teupe, C; Törmälä, P; Winckler, S | 1 |
Darkin-Rattray, S; Lawrence, JW; Neims, AH; Rowe, TC; Xie, F | 1 |
Ashton, P; Ax, D; Bierly, JR; Conklin, JD; Hainsworth, DP | 1 |
Anastasiadis, A; Andreopoulos, AG; Dounis, E; Kanellakopoulou, K; Korakis, T; Tzivelekis, P | 1 |
Cormio, L; La Forgia, P; Ruutu, M; Siitonen, A; Talja, M; Törmälä, P | 1 |
Ramchandani, M; Robinson, D | 1 |
Anwar, H; Owusu-Ababio, G; Rogers, J | 1 |
Anastassiadis, A; Andreopoulos, A; Dounis, E; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Kolia, M; Korakis, T | 1 |
Chang, TM; Wong, JP; Yu, WP | 2 |
Dash, AK; Garavalia, MJ; Haney, PW | 1 |
Ashammakhi, N; Ninkovic, M; Suokas, E; Tiainen, J; Törmälä, P; Veiranto, M; Waris, T | 1 |
Dillen, K; Ludwig, A; Van den Mooter, G; Vandervoort, J; Verheyden, L | 1 |
Aro, HT; Jalava, J; Knuuti, J; Koort, JK; Mäkinen, TJ; Suokas, E; Törmälä, P; Veiranto, M | 1 |
Dillen, K; Ludwig, A; Vandervoort, J | 1 |
Bozdag, S; Dillen, K; Ludwig, A; Vandervoort, J | 1 |
Dillen, K; Ludwig, A; Van den Mooter, G; Vandervoort, J | 1 |
Ashammakhi, N; Ikäheimo, I; Koskela, M; Länsman, S; Niemelä, SM; Suokas, E; Syrjälä, H; Törmälä, P; Veiranto, M | 1 |
Ashammakhi, N; Niemelä, SM; Suokas, E; Tiainen, J; Törmälä, P; Veiranto, M | 1 |
Ashammakhi, N; Soini, Y; Suokas, E; Tiainen, J; Törmälä, P; Veiranto, M; Waris, T | 1 |
Arnold, MM; Berkland, C; Gorman, EM; Munson, EJ; Schieber, LJ | 1 |
Augustyns, K; Bridts, C; Cos, P; Dillen, K; Ludwig, A; Stevens, W; Van der Veken, P; Vandervoort, J | 1 |
Jang, MK; Jeong, YI; Kim, DG; Kim, SI; Lee, HC; Na, HS; Na, SK; Nah, JW; Roh, SH; Seo, DH | 1 |
Aro, HT; Jalava, J; Koort, JK; Makinen, TJ; Suokas, E; Tormala, P; Veiranto, M | 1 |
Isotalo, T; Kellomäki, M; Kotsar, A; Martikainen, P; Mikkonen, J; Salenius, JP; Talja, M; Tammela, TL; Uurto, I | 1 |
Behlau, I; Ciolino, JB; Dohlman, CH; Hoare, TR; Iwata, NG; Kohane, DS; Langer, R | 1 |
Ashammakhi, N; Kaarela, O; Knuutila, K; Länsman, S; Suokas, E; Tiainen, J; Törmälä, P; Veiranto, M | 1 |
Jeong, YI; Lee, HC; Na, HS; Nah, JW | 1 |
Belfort, R; Cardillo, JA; Höfling-Lima, AL; Kuppermann, BD; Lucena, DR; Melo, LA; Nguyen, QD; Oliveira, AG; Paganelli, F; Silva, AA | 1 |
Cardillo, JA; Melo, LA; Oliveira, AG; Paganelli, F; Pizzolitto, AC; Silva, AA | 1 |
Jonnalagadda, S; Makoid, M; Park, PI | 1 |
Cheow, WS; Hadinoto, K | 1 |
Elkheshen, SA; Mobarak, DH; Salah, S | 1 |
Chaudhari, PN; Garnaik, B; Mohite, KK; Nande, SS; Parwe, SP; Selukar, BS | 1 |
Alvarez-Lorenzo, C; Concheiro, A; Mano, JF; Oliveira, NM; Rial-Hermida, MI | 1 |
He, W; Huo, X; Li, S; Li, Z; Ma, C; Song, X; Tian, J; Wei, W | 1 |
Bandara, HM; Fu, Y; Hua, X; Liu, S; Smyth, HD; Tan, S | 1 |
Astola, J; Baelo, A; Crespo, A; Engel, E; Gavaldà, J; Julián, E; Levato, R; Mateos-Timoneda, MA; Torrents, E | 1 |
Di, J; Gu, Z; Hu, Q; Jiang, X; Kim, J | 1 |
Han, CC; Tang, J; Wang, H; Xia, Q; Xu, S; Zhang, Z | 1 |
Nojehdehian, H; Tabatabaei, FS; Torshabi, M | 1 |
Chen, M; Eckmann, L; Gao, W; Gong, H; Thamphiwatana, S; Zhang, J; Zhang, L; Zhang, Y | 1 |
Prestidge, C; Richter, K; Thierry, B; Thomas, N; Thorn, C | 1 |
Günday Türeli, N; Schneider, M; Türeli, AE | 2 |
Günday Türeli, N; Juntke, J; Lehr, CM; Schneider, M; Schneider-Daum, N; Schwarz, BC; Torge, A; Türeli, AE | 1 |
Das, G; Ramesh, A; Thiyagarajan, D | 1 |
Christensen, LP; Kłodzińska, SN; Liu, X; Nielsen, HM; Nielsen, LH; Qu, H; Rantanen, J; Yang, M | 1 |
Baszczyňski, O; Procházková, E; Tichotová, M; Đud, M | 1 |
1 trial(s) available for ciprofloxacin and lactic acid
Article | Year |
---|---|
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
Topics: Aged; Anterior Chamber; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Connective Tissue; Delayed-Action Preparations; Double-Blind Method; Drug Carriers; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Inflammation; Injections; Intraocular Pressure; Intraoperative Care; Lactic Acid; Lens Implantation, Intraocular; Male; Microscopy, Acoustic; Ophthalmoscopy; Phacoemulsification; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Postoperative Complications; Prednisolone; Triamcinolone Acetonide; Uveitis, Anterior | 2009 |
49 other study(ies) available for ciprofloxacin and lactic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ciprofloxacin-impregnated poly-L-lactic acid drug carrier. New aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections.
Topics: Biological Assay; Bone Diseases; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Gentamicins; Humans; Infections; Lactates; Lactic Acid; Methylmethacrylates; Polyesters; Polymers; Time Factors | 1992 |
4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells.
Topics: Animals; Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA, Mitochondrial; DNA, Neoplasm; Lactates; Lactic Acid; Leukemia L1210; Mice; Mitochondria; Models, Genetic; Nalidixic Acid; Oxygen Consumption; Tumor Cells, Cultured | 1993 |
Intravitreal delivery of ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye; In Vitro Techniques; Lactic Acid; Polyesters; Polymers; Polyvinyl Alcohol; Rabbits | 1996 |
In vitro release of new quinolones from biodegradable systems: a comparative study.
Topics: Anti-Infective Agents; Biodegradation, Environmental; Ciprofloxacin; Culture Media; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Lactic Acid; Molecular Weight; Ofloxacin; Polyesters; Polymers; Time Factors | 1996 |
Immersion in antibiotic solution prevents bacterial adhesion onto biodegradable prostatic stents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Biodegradation, Environmental; Ciprofloxacin; Equipment Contamination; Escherichia coli; Humans; Lactic Acid; Male; Polyesters; Polyglycolic Acid; Polymers; Prostatic Diseases; Stents; Tobramycin | 1997 |
In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
Topics: Animals; Anti-Infective Agents; Biocompatible Materials; Capsules; Ciprofloxacin; Disease Models, Animal; Drug Carriers; Drug Implants; Femur; Lactic Acid; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Time Factors | 1998 |
Effectiveness of ciprofloxacin microspheres in eradicating bacterial biofilm.
Topics: Anti-Infective Agents; Bacteria; Biofilms; Ciprofloxacin; Delayed-Action Preparations; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Polyesters; Polymers; Pseudomonas aeruginosa; Staphylococcus aureus; Time Factors | 1999 |
Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxanes; Drug Carriers; Lactic Acid; Molecular Weight; Pefloxacin; Polyesters; Polymers; Solubility | 1999 |
Biodegradable polylactic acid nanocapsules containing ciprofloxacin: preparation and characterization.
Topics: Biodegradation, Environmental; Buffers; Capsules; Chemistry, Pharmaceutical; Ciprofloxacin; Delayed-Action Preparations; Drug Stability; Lactic Acid; Particle Size; Phosphatidylcholines; Polyesters; Polymers; Solubility; Time Factors | 1999 |
Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems.
Topics: Anti-Infective Agents; Calibration; Capsules; Chromatography, High Pressure Liquid; Ciprofloxacin; Infusion Pumps, Implantable; Lactic Acid; Microdialysis; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results; Solubility | 1999 |
Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
Topics: Anti-Infective Agents; Biodegradation, Environmental; Capsules; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Storage; Lactic Acid; Polyesters; Polymers | 2000 |
Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones.
Topics: Absorbable Implants; Adult; Aged; Anti-Infective Agents; Biocompatible Materials; Bone Screws; Cadaver; Ciprofloxacin; Confidence Intervals; Drug Carriers; Equipment Design; Equipment Failure; Humans; Lactic Acid; Male; Materials Testing; Microscopy, Electron, Scanning; Middle Aged; Miniaturization; Parietal Bone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Statistics as Topic; Stress, Mechanical; Surface Properties; Tensile Strength; Weight-Bearing | 2002 |
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Crystallization; Drug Compounding; Factor Analysis, Statistical; Gamma Rays; Lactic Acid; Microbial Sensitivity Tests; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pseudomonas aeruginosa; Solutions; Staphylococcus aureus; Sterilization; Temperature; X-Ray Diffraction | 2004 |
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Ciprofloxacin; Coated Materials, Biocompatible; Disease Models, Animal; Fluorodeoxyglucose F18; Glass; Humans; Lactic Acid; Male; Microspheres; Osteomyelitis; Polyesters; Polymers; Rabbits; Radiopharmaceuticals; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tomography, Emission-Computed; Treatment Outcome | 2005 |
Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use.
Topics: Ciprofloxacin; Eye Infections, Bacterial; Lactic Acid; Nanostructures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility | 2005 |
The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cryoprotective Agents; Drug Stability; Freeze Drying; Gamma Rays; Lactic Acid; Microspheres; Nanostructures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Sterilization | 2005 |
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Topics: Acrylic Resins; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Ciprofloxacin; Delayed-Action Preparations; Lactic Acid; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pseudomonas aeruginosa; Solubility; Staphylococcus aureus | 2006 |
Self-reinforced ciprofloxacin-releasing polylactide-co-glycolide 80/20 inhibits attachment and biofilm formation by Staphylococcus epidermidis: an in vitro study.
Topics: Anti-Infective Agents; Biofilms; Ciprofloxacin; Coated Materials, Biocompatible; Dental Implants; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Staphylococcus epidermidis | 2006 |
Innovation in multifunctional bioabsorbable osteoconductive drug-releasing hard tissue fixation devices.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Bone Screws; Ciprofloxacin; Drug Delivery Systems; Fibula; Fracture Fixation, Internal; Fracture Healing; Glass; Humans; Internal Fixators; Lactic Acid; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Skull | 2006 |
Tissue reactions to bioabsorbable ciprofloxacin-releasing polylactide-polyglycolide 80/20 screws in rabbits' cranial bone.
Topics: Animals; Anti-Infective Agents; Bone Screws; Ciprofloxacin; Drug Delivery Systems; Inflammation; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Skull | 2006 |
NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
Topics: Aerosols; Anti-Infective Agents; Capsules; Ciprofloxacin; Delayed-Action Preparations; Lactic Acid; Lung; Microspheres; Nanoparticles; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity | 2007 |
Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas.
Topics: Adhesiveness; Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Electrochemistry; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polymethacrylic Acids; Pseudomonas aeruginosa; Staphylococcus aureus | 2008 |
Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Escherichia coli; Kinetics; Lactic Acid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Technology, Pharmaceutical | 2008 |
Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Delayed-Action Preparations; Drug Implants; Humans; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polymers; Rabbits | 2008 |
Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Dexamethasone; Drug-Eluting Stents; Indomethacin; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Design; Rabbits; Urethra; Urethral Stricture | 2009 |
A drug-eluting contact lens.
Topics: Anti-Infective Agents; Biocompatible Materials; Ciprofloxacin; Contact Lenses, Hydrophilic; Drug Delivery Systems; Fluorescein; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polyhydroxyethyl Methacrylate; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2009 |
Pull-out strength of multifunctional bioabsorbable ciprofloxacin-releasing polylactide-polyglycolide 80/20 tacks: an experimental study allograft cranial bone.
Topics: Absorbable Implants; Adult; Aged; Anti-Infective Agents; Biocompatible Materials; Bone Nails; Cadaver; Ciprofloxacin; Diffusion; Equipment Design; Humans; Lactic Acid; Male; Materials Testing; Microscopy, Electron, Scanning; Middle Aged; Parietal Bone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stress, Mechanical; Surface Properties; Tensile Strength | 2009 |
Preparation of ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) microspheres and its antibacterial activity.
Topics: Algorithms; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chromatography, Gel; Ciprofloxacin; Excipients; Female; Lactic Acid; Mice; Mice, Inbred BALB C; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Salmonella Infections; Salmonella typhimurium | 2009 |
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Conjunctiva; Delayed-Action Preparations; Drug Carriers; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone; Vitreous Body | 2010 |
The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Implants; Excipients; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Temperature; Transition Temperature; Viscosity | 2011 |
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Carriers; Emulsions; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Synthesis of ciprofloxacin-conjugated poly (L-lactic acid) polymer for nanofiber fabrication and antibacterial evaluation.
Topics: Anti-Bacterial Agents; Cell Survival; Ciprofloxacin; Lactic Acid; Nanocapsules; Nanofibers; Particle Size; Polyesters; Polymers; Staphylococcus aureus | 2014 |
Bioinspired superamphiphobic surfaces as a tool for polymer- and solvent-independent preparation of drug-loaded spherical particles.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Delayed-Action Preparations; Dioxanes; Drug Carriers; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Ciprofloxacin; Cultured Milk Products; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Bacterial; Enterococcus; Lactic Acid; Lactobacillus; Microbial Sensitivity Tests; Mutation; Norfloxacin; Quinolones; Yogurt | 2015 |
Externally controlled triggered-release of drug from PLGA micro and nanoparticles.
Topics: Biofilms; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Humans; Lactic Acid; Magnetite Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Cell Line; Ciprofloxacin; Deoxyribonuclease I; DNA; Drug Carriers; Drug Liberation; Extracellular Matrix; Lactic Acid; Mice; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polylysine; Pseudomonas aeruginosa; Staphylococcus aureus | 2015 |
Spatiotemporal drug delivery using laser-generated-focused ultrasound system.
Topics: Alginates; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Ciprofloxacin; Delayed-Action Preparations; Dimethylpolysiloxanes; Disk Diffusion Antimicrobial Tests; Doxorubicin; Drug Carriers; Equipment Design; Escherichia coli; Gels; Glucuronic Acid; HeLa Cells; Hexuronic Acids; Humans; Kinetics; Lactic Acid; Lasers; Nanoparticles; Photoacoustic Techniques; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Soot; Spheroids, Cellular; Technology, Pharmaceutical; Transducers; Ultrasonic Waves; Ultrasonics | 2015 |
Controlled Antibiotics Release System through Simple Blended Electrospun Fibers for Sustained Antibacterial Effects.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Lactic Acid; Membranes, Artificial; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Polydioxanone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2015 |
In vitro behavior of poly-lactic-co-glycolic acid microspheres containing minocycline, metronidazole, and ciprofloxacin.
Topics: Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Combinations; In Vitro Techniques; Lactic Acid; Metronidazole; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microspheres; Minocycline; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
A Bioadhesive Nanoparticle-Hydrogel Hybrid System for Localized Antimicrobial Drug Delivery.
Topics: Acrylamides; Adhesives; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Dopamine; Drug Delivery Systems; Escherichia coli; HEK293 Cells; Humans; Hydrogels; Lactic Acid; Mice; Mice, Inbred ICR; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin | 2016 |
Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Carriers; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus; Treatment Outcome | 2016 |
Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond.
Topics: Ciprofloxacin; Drug Carriers; Drug Liberation; Ions; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa | 2016 |
Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
Topics: Anti-Bacterial Agents; Biofilms; Chemistry, Pharmaceutical; Ciprofloxacin; Cystic Fibrosis; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Lung; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
Topics: Animals; Cell Line; Ciprofloxacin; Cystic Fibrosis; Drug Carriers; Horses; Humans; Lactic Acid; Mucus; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Respiratory Mucosa; Respiratory Tract Infections | 2017 |
Amphiphilic Cargo-Loaded Nanocarrier Enhances Antibiotic Uptake and Perturbs Efflux: Effective Synergy for Mitigation of Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Cell Survival; Ciprofloxacin; Drug Carriers; Gentamicins; HEK293 Cells; Humans; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Ciprofloxacin-loaded sodium alginate/poly (lactic-co-glycolic acid) electrospun fibrous mats for wound healing.
Topics: Alginates; Anti-Bacterial Agents; Bandages; Ciprofloxacin; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Wound Healing | 2018 |
Phosphate-Based Self-Immolative Linkers for the Delivery of Amine-Containing Drugs.
Topics: Amines; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Hydrogen-Ion Concentration; Lactic Acid; Pharmaceutical Preparations; Phosphates; Prodrugs | 2021 |